Citation Impact

Citing Papers

Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
2006 StandoutScience
Optimal Dissociation Methods Differ for N - and O -Glycopeptides
2020 StandoutNobel
IL-33 Induces IL-13–Dependent Cutaneous Fibrosis
2009
Depression rating scales in Parkinson's disease: Critique and recommendations
2007
Glycoproteogenomics: A Frequent Gene Polymorphism Affects the Glycosylation Pattern of the Human Serum Fetuin/α-2-HS-Glycoprotein
2019
Inflammation and Alzheimer's disease
2000 Standout
The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes
2003 Standout
The Retinal Pigment Epithelium in Visual Function
2005 Standout
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
2011 Standout
The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease
2002
Aβ Oligomers – a decade of discovery
2007 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Oxidative Stress Hypothesis in Alzheimer's Disease
1997 Standout
Structure and function of the blood–brain barrier
2009 Standout
Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease
2004 Standout
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
2017 Standout
Neurobiology of emotion perception I: the neural basis of normal emotion perception
2003 Standout
Parkinson's disease: clinical features and diagnosis
2008 Standout
Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation inalpha2‐macroglobulinandtau: A population‐based autopsy study
2008
The Endosomal-Lysosomal System of Neurons in Alzheimer's Disease Pathogenesis: A Review
2000
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
2007 Standout
Overdependence on degraded gist memory in Alzheimer's disease.
2006 Standout
Association between an α2 Macroglobulin DNA Polymorphism and Late-Onset Alzheimer's Disease
1999
The deletion polymorphism and Val1000Ile in α-2-macroglobulin and Alzheimer disease in Caribbean Hispanics
2000
Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Aβ42 and decreased Aβ40
2006
In vivo imaging of synaptic function in the central nervous system
2009
Low-Density Lipoprotein Receptor Family
2001
Dementia: The neurochemical basis of putative transmitter orientated therapy
1991
EFNS guidelines for the diagnosis and management of Alzheimer’s disease
2010
Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval
2002
A2E-epoxides Damage DNA in Retinal Pigment Epithelial Cells
2003
Alpha and Gamma Tocopherols in Cerebrospinal Fluid and Serum from Older, Male, Human Subjects
2004
Clonidine enhances delayed matching-to-sample performance by young and aged monkeys
1991
Structural and functional features of central nervous system lymphatic vessels
2015 StandoutNature
Functional Neuroanatomy of Emotion: A Meta-Analysis of Emotion Activation Studies in PET and fMRI
2002 Standout
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Memory Impairment Differs in Frontotemporal Dementia and Alzhemier’s Disease.
2001
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings
2002
The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates
2018
Therapeutic implications of the gender-specific aspects of cardiovascular disease
2006
Cupric–amyloid β peptide complex stimulates oxidation of ascorbate and generation of hydroxyl radical
2003
The alpha-2 macroglobulin gene is not associated with Alzheimer's disease in a case-control sample
1999
Differences in depression symptoms in patients with Alzheimer's and Parkinson's diseases: evidence from the 15‐item Geriatric Depression Scale (GDS‐15)
2007
Systemic amyloidosis
2015 Standout
Amyloid-β: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer’s disease
2001
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation
2006 Standout
Arisugacins, selective acetylcholinesterase inhibitors of microbial origin
1997 StandoutNobel
Amyloid-β is an antioxidant for lipoproteins in cerebrospinal fluid and plasma
2001
The Low Density Lipoprotein Receptor-related Protein 1B Retains β-Amyloid Precursor Protein at the Cell Surface and Reduces Amyloid-β Peptide Production
2004
Alzheimer's Disease
2010 Standout
The Amyloid State of Proteins in Human Diseases
2012 Standout
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
2020 StandoutNobel
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
2003 Standout
Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer’s Disease?
2016
Neurodegenerative diseases and oxidative stress
2004 Standout
Oxidative stress and neurodegeneration: where are we now?
2006 Standout
Loss of disgust
1996
Intracellular amyloid-β in Alzheimer's disease
2007 Standout
Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040
2014 Standout
Lipid peroxidation in neurodegeneration: new insights into Alzheimerʼs disease
2002
Molecular Mechanisms of Amyloidosis
2003 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
The molecular pathology of Alzheimer's disease
1991 Standout
Assessment of Neuroinflammation and Microglial Activation in Alzheimer’s Disease with Radiolabelled PK11195 and Single Photon Emission Computed Tomography
2003
Novel Presenilin 1 Mutation (S170F) Causing Alzheimer Disease With Lewy Bodies in the Third Decade of Life
2005
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
2010 Standout
A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine
2005 Standout
Genetic association of alpha2-macroglobulin with Alzheimer's disease in a Finnish elderly population.
1999
INFLAMMATION AND ALZHEIMERS DISEASE
2000
Abnormal Synaptic Plasticity and Impaired Spatial Cognition in Mice Transgenic for Exon 1 of the Human Huntington's Disease Mutation
2000
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Genetic association of ?2-macroglobulin with Alzheimer's disease in a Finnish elderly population
1999
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
Contrasting, Species-Dependent Modulation of Copper-Mediated Neurotoxicity by the Alzheimer's Disease Amyloid Precursor Protein
2002
The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies
2021 Standout
Mutation of the α2A-Adrenoceptor Impairs Working Memory Performance and Annuls Cognitive Enhancement by Guanfacine
2002 StandoutNobel
Alzheimer's Disease: Genes, Proteins, and Therapy
2001 Standout
Vitamin C and Vitamin E for Alzheimer's Disease
2005
The Genetics of the Amyloidoses
2000
The Role ofVldlrin Intraretinal Angiogenesis in Mice
2011 StandoutNobel
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
Biological Markers in Alzheimer Disease
2002
[The Rotterdam study].
2011
Selective Discrimination Learning Impairments in Mice Expressing the Human Huntington's Disease Mutation
1999
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
Integrating mechanisms of pulmonary fibrosis
2011 Standout
LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia
2006 Standout

Works of Ulrike Mann being referenced

Depression in Alzheimer’s Disease Might Be Associated with Apolipoprotein E ε4 Allele Frequency in Women but Not in Men
2002
Increased lipoprotein oxidation in alzheimer’s disease
2000
Genetic association of an ( 2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease
1998
Detecting depression in Alzheimer?s disease: evaluation of four different scales
2004
Loss of glycosylation associated with the T183A mutation in human prion disease
2004
Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer’s disease
2001
Clonidine Treatment of Alzheimer's Disease
1989
Overexpression of IL-4 Alters the Homeostasis in the Skin
2002
High Prevalence of Pathogenic Mutations in Patients with Early-Onset Dementia Detected by Sequence Analyses of Four Different Genes
2000
Visuospatial cognition in Huntington's disease
1991
High Frequency of Mutations in Four Different Disease Genes in Early‐Onset Dementia
2000
A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia
1992
Heterogeneity in Alzheimer's disease: progression rate segregated by distinct neuropsychological and cerebral metabolic profiles.
1992
Rankless by CCL
2026